Researchers at the University of Pennsylvania have been developing and testing a new cancer treatment that reprograms T-cells using a disabled form of HIV to fight leukemia. The New York Times tells the story of Emma Whitehead, a seven-year-old who is now in complete remission after receiving a T-cell transplant to combat the disease. So far, only twelve patients have received the experimental treatment, but four of them — including Emma — have made a full recovery as a result. For more on the new technique that some doctors say could be a "major breakthrough," check out the full article at the source link below.
We'll email you a reset link.
If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.
Choose an available username to complete sign up.
In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.